AI is changing how we answer the first question on every trial: can this be done, where and how fast?

This is what AI-Augmented feasibility looks like at TFS.

Feasibility sets the trajectory of every trial. Get the country mix wrong, miss a site, underestimate competitive density and a Phase II slips by six months before it has started. The pressure to get it right and get it fast, has always been there. Now the tools to do both exist.

TFS HealthScience has integrated AI into its feasibility methodology not to replace the judgement that makes a recommendation rigorous, but to remove the bottleneck that slows it down.

In this case study you will find:

  • Where AI runs and where experienced feasibility leads take over
  • How 4 in 5 feasibilities in 2026 used this approach to deliver a 35% faster turnaround

The result is a faster path from a sponsor’s first question to a credible answer and a faster trial.

Download the case study to see how it works.

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Latest resources

 

Co design
Designed with, not for: co-designing clinical trials with patients at the table, not in the waiting roomArticle

Designed with, not for: co-designing clinical trials with patients at the table, not in the waiting room

Most CROs bring patient groups in after the protocol is locked. TFS HealthScience explains why that timing determines whether co-design actually works.
Juneteenth
Juneteenth and the next chapter of medicineArticle

Juneteenth and the next chapter of medicine

From site selection to protocol design, inclusive trials produce better science. TFS HealthScience on closing the representation gap.
LGBTQ+
This Pride Month see the life behind every numberArticle

This Pride Month see the life behind every number

LGBTQ+ patients want to take part in clinical research. Most are never asked. Here is what the science says and what better recruitment looks like in practice.